199 related articles for article (PubMed ID: 37456522)
1. Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer's disease.
Alalwany RH; Hawtrey T; Morgan K; Morris JC; Donaldson LF; Bates DO
Front Mol Neurosci; 2023; 16():1181626. PubMed ID: 37456522
[TBL] [Abstract][Full Text] [Related]
2. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.
Hulse RP; Beazley-Long N; Hua J; Kennedy H; Prager J; Bevan H; Qiu Y; Fernandes ES; Gammons MV; Ballmer-Hofer K; Gittenberger de Groot AC; Churchill AJ; Harper SJ; Brain SD; Bates DO; Donaldson LF
Neurobiol Dis; 2014 Nov; 71():245-59. PubMed ID: 25151644
[TBL] [Abstract][Full Text] [Related]
3. VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.
Beazley-Long N; Hua J; Jehle T; Hulse RP; Dersch R; Lehrling C; Bevan H; Qiu Y; Lagrèze WA; Wynick D; Churchill AJ; Kehoe P; Harper SJ; Bates DO; Donaldson LF
Am J Pathol; 2013 Sep; 183(3):918-29. PubMed ID: 23838428
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A
Pang V; Bates DO; Leach L
Clin Sci (Lond); 2017 Dec; 131(23):2763-2775. PubMed ID: 29054861
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of Vascular Endothelial Growth Factor-A
Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of VEGF-A
Barratt SL; Blythe T; Jarrett C; Ourradi K; Shelley-Fraser G; Day MJ; Qiu Y; Harper S; Maher TM; Oltean S; Hames TJ; Scotton CJ; Welsh GI; Bates DO; Millar AB
Am J Respir Crit Care Med; 2017 Aug; 196(4):479-493. PubMed ID: 28661183
[TBL] [Abstract][Full Text] [Related]
9. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
Hulse RP; Drake RA; Bates DO; Donaldson LF
Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
[TBL] [Abstract][Full Text] [Related]
10. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
13. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
15. Detection of VEGF-A(xxx)b isoforms in human tissues.
Bates DO; Mavrou A; Qiu Y; Carter JG; Hamdollah-Zadeh M; Barratt S; Gammons MV; Millar AB; Salmon AH; Oltean S; Harper SJ
PLoS One; 2013; 8(7):e68399. PubMed ID: 23935865
[TBL] [Abstract][Full Text] [Related]
16. The role of VEGF-A165b in trophoblast survival.
Bills VL; Hamdollah-Zadeh M; Soothill PW; Harper SJ; Bates DO
BMC Pregnancy Childbirth; 2014 Aug; 14():278. PubMed ID: 25128406
[TBL] [Abstract][Full Text] [Related]
17. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
18. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
[TBL] [Abstract][Full Text] [Related]
20. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
